Japan
· Delayed Price · Currency is JPY Alfresa Holdings Company Description
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally.
It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies.
The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies.
In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals.
Further, the company’s medical-related business includes its dispensing pharmacy and other medical-related businesses.
The company was incorporated in 2003 and is based in Tokyo, Japan.
| Country | Japan |
| Founded | 2003 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 12,452 |
| CEO | Ryuji Arakawa |
Contact Details
Address: 1-1-3 Otemachi Tokyo, 100-0004 Japan | |
| Phone | 81 3 5219 5100 |
| Website | alfresa.com |
Stock Details
| Ticker Symbol | 2784 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3126340003 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Ryuji Arakawa | Chief Executive Officer |